A randomized controlled phase III trial to evaluate the effect of preoperative enteral immunonutrition on the surgical site infection after total gastrectomy (OGSG0507). Validation study of sentinel ...
Positive high-level results from a planned interim analysis of the MATTERHORN phase III trial showed treatment with AstraZeneca’s Imfinzi (durvalumab) added to standard-of-care FLOT (fluorouracil, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback